Losartan Market to Grow at a Rate of 7.81% During 2026

Growing prevalence of hypertension is expected to drive the growth of the Global Losartan market.

According to TechSci Research report, “Global Losartan Market By Source (Contract Manufacturing Organizations, In-House), By Form (Tablet, Powder), By Strength (25mg, 50mg, 100mg, Others), By Distribution Channel (Offline, Online), By Application (Hypertension, Stroke, Diabetic nephropathy, Others), By End-User (Adult, Pediatric), By Region, Forecast & Opportunities, 2026”, the Global Losartan market is expected to grow at a steady rate of 7.81% during the forecast period. The Global Losartan market was valued at USD4.73 billion in 2020. Losartan is an angiotensin II receptor blocker and is available as losartan potassium oral tablets as well as a combination tablet of losartan potassium and hydrochlorothiazide. The consumption of Losartan also delays the progression of diabetic nephropathy which is expected to fuel the market growth through 2026. However, side-effects associated with drug consumption also delay the progression of diabetic nephropathy can restrict the market growth over the next few years. Along with this, patients suffering from type 2 diabetes and kidney disease may experience diarrhea, low blood pressure, fatigue, low blood glucose, chest pain, elevated potassium, or allergic reaction. This can further reduce the usage and application of the drug, thereby hindering the market growth during the forecast period.

Browse 293 market Figures spread through 110 Pages and an in-depth TOC on “Global Losartan Market”

https://www.techsciresearch.com/report/losartan-market/7269.html

The Global Losartan market is segmented based on source, form, strength, distribution channel, application, end user, company, and region. Based on application, the market can be fragmented into hypertension, stroke, diabetic nephropathy, and others. The hypertension segment is expected to dominate the market in the forthcoming years on account of the rising count of patients having high blood pressure problems in the country. Based on source, the market can be categorized into in-house v/s contract manufacturing organizations. Among these, the in-house segment is expected to witness the fastest growth in the forecast period. In terms of form, the market is split into tablets and powder. Among them, the tablet segment is projected to grow at a high rate in the next five years on account of multiple benefits it provides such as ease of availability, affordable price, etc. Also, they offer faster relief from symptoms when compared to powder. This is further contributing to its fast-growing CAGR in the years to come. Based on strength, the market is segmented into 25 mg, 50 mg, 100 mg and others. Among these, the 25 mg segment is expected to dominate the market because of the higher demand and supply of these tablets. Furthermore, the market can also be segmented on the basis of distribution channel which is categorized into offline and online. The offline segment is leading the market and is expected to maintain its position in the coming years as well. The prime reason for the higher share of offline sales is due to Losartan being a prescribed medicine which is not available over the counter without the doctor’s prescription. Apart from this, the market is also segmented on the basis of end-user which is sub-segmented into adult and pediatric. The adult segment is leading the market and is expected to maintain its lead in the forecast period as well.

Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis International AG, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceuticals Industries Ltd., Aurobindo Pharma Ltd., Torrent Pharmaceutical Ltd., Lupin Ltd., Mylan N.V., Ipca Laboratories Limited, Macleods Pharmaceuticals Limited, Abbott Laboratories, Cadila Healthcare Limited, and others are some of the leading players operating in the Global Losartan market. Companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share and increase their geographic reach.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7269

Customers can also request for 10% free customization on this report.

“Global Losartan market is expected to witness growth during the forecast period as it is used to treat hypertensive patients with left ventricular hypertrophy. Further, it reduces the risk of stroke in patients having high blood pressure problems which is further expected to create lucrative opportunities for the market growth of the Global Losartan market over the next five years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based India management consulting firm.

“Global Losartan Market By Source (Contract Manufacturing Organizations, In-House), By Form (Tablet, Powder), By Strength (25mg, 50mg, 100mg, Others), By Distribution Channel (Offline, Online), By Application (Hypertension, Stroke, Diabetic nephropathy, Others), By End-User (Adult, Pediatric), By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of the Global Losartan market and provides statistics and information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in the Global Losartan market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]